Impact of Xerosis in Patients With Cancer Receiving Epidermal Growth Factor Receptor or Mitogen-Activated Protein Kinase Inhibitors: ATIXI, A Non-Interventional, Prospective, Pilot Study

• Pietro Quaglino,
• Giuseppe Argenziano,
• Emi Dika,
• Michela Starace,
• Simone Amabile,
• Paolo Fava,
• Elvira Moscarella,
• Bianca Maria Piraccini,
• Alain Delarue,
• Olivia Dialla,
• Fabienne Zumaglini,
• Giampiero Girolomoni

Affiliations

Pietro Quaglino

Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy

Giuseppe Argenziano

Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli Naples, Naples, Italy

Emi Dika

Oncologic Dermatology Unit , IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy Department of Medical and Surgical Sciences , Alma Mater Studiorum University of Bologna, Italy

Michela Starace

Department of Medical and Surgical Sciences , Alma Mater Studiorum University of Bologna, Italy Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy

Simone Amabile

Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy

Paolo Fava

Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy

Elvira Moscarella

Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli Naples, Naples, Italy

Bianca Maria Piraccini

Department of Medical and Surgical Sciences , Alma Mater Studiorum University of Bologna, Italy Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy

Alain Delarue

Pierre Fabre, Lavaur, France

Olivia Dialla

Pierre Fabre, Boulogne-Billancourt, France

Fabienne Zumaglini

Pierre Fabre, Lavaur, France

Giampiero Girolomoni

Department of Medicine, Section of Dermatology, University of Verona, Verona, Italy